URL details: genetxbio.com/news/genetx-and-ultragenyx-announce-fda-has-removed-clinical-hold-on-phase-12-clinical-study-of-gtx-102-for-the-treatment-of-angelman-syndrome-in-the-us
URL title:
Ultragenyx—Treatment of Rare and Ultrarare Genetic Diseases
URL description:
Ultragenyx is focused on developing first-ever approved treatments for rare and ultrarare diseases and moving the rare disease community forward.
URL last crawled:
2024-07-26
URL speed:
0.220 MB/s,
downloaded in 0.400 seconds
We found no external links pointing to this url.